Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wonjun Ji

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Thoracic Cancer|July 29, 2022
Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean populationDa Som Jeon, Jin Woo Kim, Seul Gi Kim, et al.
BMC Medical Informatics and Decision Making|January 7, 2023
Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative databaseMin-Hyung Kim, Sojung Park, Yu Rang Park, et al.
Biochemical and Biophysical Research Communications|September 13, 2023
AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8<sup>+</sup> T cells by inducing CD103<sup>+</sup> dendritic cell-mediated T cell primingKyungtaek Im, Yun Jung Choi, Dong Ha Kim, et al.
Respiratory Research|February 2, 2017
Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosisPhilip L Molyneaux, Michael J Cox, Athol U Wells, et al.
Thoracic Cancer|March 22, 2021
Diagnostic yield and safety of biopsy guided by electromagnetic navigation bronchoscopy for high-risk pulmonary nodulesJu Hyun Oh, Chang-Min Choi, Seulgi Kim, et al.
Biomedicines|February 26, 2025
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and ChallengesJeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
JMIR Mhealth and Uhealth|June 23, 2019
Mobile Health Management Platform-Based Pulmonary Rehabilitation for Patients With Non-Small Cell Lung Cancer: Prospective Clinical TrialWonjun Ji, Hee Kwon, Sungin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2025
Clinical effect of pulmonary rehabilitation during radiotherapy in lung cancer: A randomized controlled trialJang Ho Lee, Seungwoo Cha, Eun Jae Ko, et al.
Journal of Clinical Medicine|January 21, 2022
CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung CancerYunha Nam, Chang-Min Choi, Young Soo Park, et al.
BMC Pulmonary Medicine|May 17, 2024
A prospective, open-label, randomized clinical trial to evaluate the efficacy and safety of remimazolam in patients undergoing EBUS-TBNA: REST trial designHee Yun Seol, Kyung Soo Hong, Jong Geol Jang, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Thoracic Cancer|July 29, 2022
Sex differences in the characteristics and survival of patients with non-small-cell lung cancer: A retrospective analytical study based on real-world clinical data of the Korean populationDa Som Jeon, Jin Woo Kim, Seul Gi Kim, et al.
BMC Medical Informatics and Decision Making|January 7, 2023
Stratifying non-small cell lung cancer patients using an inverse of the treatment decision rules: validation using electronic health records with application to an administrative databaseMin-Hyung Kim, Sojung Park, Yu Rang Park, et al.
Biochemical and Biophysical Research Communications|September 13, 2023
AXL receptor tyrosine kinase inhibition improves the anti-tumor effects of CD8<sup>+</sup> T cells by inducing CD103<sup>+</sup> dendritic cell-mediated T cell primingKyungtaek Im, Yun Jung Choi, Dong Ha Kim, et al.
Respiratory Research|February 2, 2017
Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosisPhilip L Molyneaux, Michael J Cox, Athol U Wells, et al.
Thoracic Cancer|March 22, 2021
Diagnostic yield and safety of biopsy guided by electromagnetic navigation bronchoscopy for high-risk pulmonary nodulesJu Hyun Oh, Chang-Min Choi, Seulgi Kim, et al.
Biomedicines|February 26, 2025
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and ChallengesJeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
JMIR Mhealth and Uhealth|June 23, 2019
Mobile Health Management Platform-Based Pulmonary Rehabilitation for Patients With Non-Small Cell Lung Cancer: Prospective Clinical TrialWonjun Ji, Hee Kwon, Sungin Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|April 30, 2025
Clinical effect of pulmonary rehabilitation during radiotherapy in lung cancer: A randomized controlled trialJang Ho Lee, Seungwoo Cha, Eun Jae Ko, et al.
Journal of Clinical Medicine|January 21, 2022
CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung CancerYunha Nam, Chang-Min Choi, Young Soo Park, et al.
BMC Pulmonary Medicine|May 17, 2024
A prospective, open-label, randomized clinical trial to evaluate the efficacy and safety of remimazolam in patients undergoing EBUS-TBNA: REST trial designHee Yun Seol, Kyung Soo Hong, Jong Geol Jang, et al.
Pageof 9